Developing SDG into a European Sales and R&D Base
First written in FY2016-Q3. 8 of 20 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2026: 1 of 8 companies on the "Worse" side.
6 other companies' latest entry also says "Restated".
- FY2024-Q3RestatedAnnual report
「Going forward, MMG will seek to increase production capacity for dental restorative materials and promote sales expansion in Europe, the United States and Asia.」
The company has reconfirmed its policy of making the German site part of its global production system, increasing production capacity for dental restorative materials and expanding sales in Europe, the United States and Asia. - FY2024-Q2AdvancedAnnual report
「In addition, production delays that occurred at the new headquarters and plant of MMG, the consolidated German subsidiary, in the previous quarter have been resolved, and production has returned to normal levels. As a result, sales of MMG products, mainly dental restorative materials, are trending higher than in the previous quarter.」
Production delays associated with the launch of MMG’s new headquarters and plant have been resolved, production has returned to normal levels, and MMG product sales have begun trending higher than in the previous quarter. - FY2023AdvancedAnnual report
「At the German subsidiary MANI MEDICAL GERMANY GmbH, construction of the new headquarters and plant was completed in September 2023, and operations commenced that month. By expanding production capacity for dental restorative materials, we will promote sales expansion in Europe, the United States and Asia.」
GDF’s new headquarters and plant has reached completion, with operations commencing in September 2023, and the company is moving on to expand sales in Europe, the United States and Asia by increasing production capacity for dental restorative materials. - FY2023-Q3RestatedAnnual report
「GDF, the consolidated German subsidiary, is constructing a new headquarters and plant in Germany as part of efforts to establish a global production system, with completion scheduled for August 2023.」
The company continues construction of GDF’s new headquarters and plant and has reconfirmed the planned August 2023 completion. No new completion milestone has yet been reported following the land acquisition and start of construction. - FY2023-Q2AdvancedAnnual report
「This was attributable to a ¥313 million decrease in current assets, mainly comprising decreases of ¥568 million in inventories and ¥578 million in other current assets, partly offset by a ¥624 million increase in cash and deposits, and a ¥944 million increase in non-current assets, mainly reflecting a ¥1,579 million increase in construction in progress related to capital investment at GDF, the consolidated German subsidiary.」
The company states that capital investment related to construction of GDF’s new headquarters and plant progressed, resulting in a ¥1,579 million increase in construction in progress. - FY2023-Q1RestatedAnnual report
「GDF, the consolidated German subsidiary, is constructing a new headquarters and plant, scheduled for completion around August 2023.」
The company indicates that construction of GDF’s new headquarters and plant is continuing, with completion scheduled for around August 2023. - FY2022-Q3AdvancedAnnual report
「At the German group company, the acquisition of land for construction of a new headquarters and plant has been completed, and construction has begun with completion targeted for the next fiscal year.」
For the German site, the company reports the concrete progress of starting construction of the new headquarters and plant after completing the land acquisition, with completion targeted for the next fiscal year. - FY2022-Q2AdvancedAnnual report
「At the consolidated German subsidiary, the acquisition of land for construction of a new headquarters and plant has been completed, and the plan is progressing steadily toward completion in the next fiscal year.」
For the German site, the company reports the concrete progress of completing the acquisition of land for the new headquarters and plant, along with plans for completion in the next fiscal year. - FY2022-Q2AdvancedAnnual report
「At the consolidated German subsidiary, the acquisition of land for construction of a new headquarters and plant has been completed, and the plan is progressing steadily toward completion in the next fiscal year.」
For the German site, the company reports the concrete progress of completing the acquisition of land for the new headquarters and plant, along with plans for completion in the next fiscal year. - FY2021ReframedAnnual report
「GDF Gesellschaft für dentale Forschung und Innovationen GmbH GERMANY, HESSEN Dental New headquarters building Land, etc. Undecided 47 Internal funds 2020.3 2023.4」
In addition to joint product development and technical collaboration with GDF, the company disclosed a capital investment plan for a new building at its German site, with ¥47 million already paid, funded internally, and scheduled for completion in April 2023. - FY2021-Q3Cited as achievedAnnual report
「Sales in Europe at the overseas subsidiary GDF Gesellschaft für dentale Forschung und Innovationen GmbH remained strong.」
The company reports strong European sales at GDF as a result of its activities related to operating as a European sales hub. - FY2021-Q2AdvancedAnnual report
「We also shared marketing information with the German entity GDF Gesellschaft für dentale Forschung und Innovationen GmbH and advanced the development of new dental restorative materials.」
In addition to technical exchanges and information sharing with GDF, the company is specifically advancing mutual sharing of marketing information and the development of new dental restorative materials. - FY2019-Q3RestatedAnnual report
「We also conducted further technical exchanges and information sharing with the German entity GDF Gesellschaft für dentale Forschung and Innovationen GmbH, with the aim of expanding sales of new products in developed markets.」
The company continues to develop new products for developed markets through technical exchanges and information sharing with GDF. - FY2019-Q2RestatedAnnual report
「In development, we consolidated the development divisions for the Surgical, Eyeless Needle and Dental segments, promoting cross-segment technical exchanges and shared use of equipment. We also carried out further technical exchanges and information sharing with the German entity GDF Gesellschaft für dentale Forschung und Innovationen GmbH, with the aim of expanding sales of new products in developed markets, and focused on strengthening new product development.」
Following the transfer of Schütz Dental GmbH, the company continues technical exchanges and information sharing with the German entity GDF to expand sales of new products in developed markets and strengthen new product development. - FY2018ReframedAnnual report
「We transferred all shares in the consolidated German subsidiary Schütz Dental GmbH. In addition, to make the technology held by the German subsidiary a core technology of our Group, we will strengthen collaboration beyond previous levels and advance the development of new dental products through Co-R&D (joint research and development).」
Following the transfer of Schütz Dental GmbH, the focus is shifting from the former direction of establishing SDG as a European sales and R&D hub toward making the technology of the remaining German subsidiary a core technology and advancing joint research and development. - FY2017RestatedAnnual report
「At the German subsidiaries Schütz Dental GmbH and GDF Gesellschaft für dentale Forschung und Innovationen GmbH, collectively referred to below as “SDG,” sales of implants and dental precious metals remained sluggish in addition to the impact of the stronger yen. However, we conducted active activities to establish them as a European sales hub and developed the necessary structure to promote joint product development with our company.」
The company continues to establish SDG as a European sales hub and develop the structure for joint product development. - FY2017-Q3AdvancedAnnual report
「At the two German subsidiaries, Schütz Dental GmbH and GDF Gesellschaft für dentale Forschung und Innovationen GmbH, collectively referred to below as “SDG,” sales of implants remained sluggish in addition to the impact of the stronger yen. However, we conducted active activities to establish them as a European sales hub and developed the necessary structure to promote joint product development with our company.」
In addition to sales activities aimed at establishing SDG as a European sales hub, the company developed the necessary structure to promote joint product development with us. - FY2017-Q2RestatedAnnual report
「At the two German subsidiaries, Schütz Dental GmbH and GDF Gesellschaft für dentale Forschung und Innovationen GmbH, collectively referred to below as “SDG,” we conducted active sales activities to establish them as a European sales hub for our products, but」
The company is maintaining its direction of making SDG a European sales hub for its products and is pursuing active sales activities toward that end. - FY2016RestatedAnnual report
「At SDG as well, we will promote sales and marketing activities and achieve this by developing and launching new products on a scale far exceeding that of the past.」
The company is maintaining its direction of developing SDG as a European sales and R&D hub and will advance sales and marketing activities and new product launches. - FY2016-Q3First statedAnnual report
「At SDG, we continue to develop the necessary infrastructure to establish it at an early stage as a European sales and R&D base for our products.」
States the policy of establishing the acquired German subsidiaries, SDG, as a European sales and R&D base.